Buy Trastuzumab 440 mg Lyophilized Powder | Oncology Supply – Gilla Pharma
Trastuzumab 440 mg Lyophilized Powder for Injection is a targeted monoclonal antibody therapy indicated for the treatment of HER2-positive breast and gastric cancers. By specifically binding to HER2 receptors, Trastuzumab blocks tumor cell growth and activates immune-mediated cancer cell destruction.
This biologic therapy is a cornerstone treatment in HER2-positive oncology protocols and is administered via intravenous infusion under specialist supervision.
Key Features:
- Strength: 440 mg
- Dosage Form: Lyophilized Powder for IV Injection
- Drug Class: Monoclonal Antibody (HER2 inhibitor)
- Indications: HER2-positive breast & gastric cancers
- Route: Intravenous infusion
Why Choose Gilla Pharma?
Gilla Pharma supplies high-quality oncology medicines across Myanmar, Vietnam, Cambodia, Laos, and Indonesia, ensuring:
- Reliable sourcing
- Competitive wholesale pricing
- Regulatory-compliant documentation
- Secure international distribution
We supply exclusively to licensed hospitals, oncology centers, and authorized healthcare providers.
Product Specifications
| Attribute | Details |
|---|---|
| Generic Name | Trastuzumab |
| Strength | 440 mg |
| Dosage Form | Lyophilized Powder for Injection |
| Drug Class | Monoclonal Antibody |
| Indications | HER2-positive cancers |
| Route | Intravenous |
Request a Quote for Zoledronic Acid Injection 4 mg
For bulk supply, pricing, or regulatory documentation, contact Gilla Pharma today.
📩 Email: info@gillapharma.com
📞 Phone: +91 95491 32929 | +84 7645 21324
